As home to pharmaceutical and biomedical leaders such as Pfizer, OSI Pharmaceuticals and Regeneron, New York State has committed to and realized considerable biomedical industry growth. This is due, in part, to the many billions of dollars New York State has spent in the last decade to expand businesses and create new high technology and biotechnology opportunities. This includes $225 million under the Gen*NY*sis Program (Generating Employment through New York State Science)—a program focused on all stages of the life sciences research and development process, from basic research to applied research to final product, encouraging collaboration between public and private research institutions with both emerging and established companies.
New York State is ranked:

  • 1st  in the nation as top state for biotech growth
    Business Facilities Magazine, July 2006
  • 2nd in total bioscience employment with 92,221 employees
    County Business Patterns, 2006; Non-Employer Series, 2006
  • 3rd  in the nation in number of grant awards provided to research institutions at 5,078 and a value of $2.32 billion
    National Institute of Health, 2009 
    New York had 10 institutions ranked among the top 100 in terms of receiving grants, including Columbia University, Yeshiva University, Mount Sinai School of Medicine, New York University, Sloan-Kettering Institute for Cancer Research and The Rockefeller University.
  • 2nd  in academic research and development expenditures at nearly $3.8 billion in 2006, with three institutions in the top 20 and 11 institutions in the top 100
    National Science Foundation’s Division of Science Resources Statistics in 2006, Business Facilities
  • 2nd in developing biotechnology based on 8 factors, including the number of establishments in agricultural feedstocks and chemicals, drugs and pharmaceuticals, medical devices and equipment and research and testing Business Facilities, July 2005
  • 2nd  in life sciences Research & Development (R&D) expenditures ($2.5 billion)
    NIH Awards to Institutions and Higher Education, 2009
  • 3rd in the nation in total higher education degrees in biological sciences at nearly 6,400
    Biotechnology Industry Organization Study conducted by the Battelle Memorial Institute, The State Science and Technology Institute, and Fleishman-Hillard International Communications, May 2004
  • 2nd in the nation in number of  advanced science and engineering degrees awarded at 13,543 (2007), up from 11,511 in 2002
    National Science Foundation, 2010
  • 15th in scientists and engineers as a percentage of the workforce (2007)
    The 2007 State New Economy Index, Ewing Kauffman Foundation and Information Technology and Innovation Foundation
  • The NYC metro area named one of the Top 5 Biotech Regions for its commitment to the biotech sector through its proposed development of commercial lab space for small and mid-sized companies at East River Science Park and the Brooklyn Army Terminal
    FierceBiotech, 2009.


Research Facilities
New York State is home to leading research facilities and Strategically Targeted Academic Research (STAR) Centers that encompass top international medical researchers. With the State’s visionary strategy of leveraging both public and private sector funds, these facilities have set the stage for future growth in the field. New York’s commitment delivers strong economic benefits to the State by expanding job growth and identifying new business opportunities for established and emerging businesses. The State has provided funding for the following resources which contribute to New York’s extraordinary life sciences infrastructure:
New York’s Center of Excellence in Bioinformatics and Life Sciences at State University of New York (SUNY) Buffalo seeks to discover target molecules for use in molecular diagnostics and therapeutic development. The collaboration includes the State University of New York at Buffalo, the New York Health Department’s Roswell Park Cancer Institute, the Hauptman Woodward Medical Research Institute and several private life science firms.
Also at SUNY Buffalo are:
The Center of Disease Modeling and Therapy Discovery conducts research to develop new therapies to prevent and treat diseases. This STAR Center’s chief partners are Roswell Park Cancer Institute, Hauptman-Woodward Medical Research Institute, Kaleida Health, SUNY Albany and IBM.
The Institute for Lasers, Photonics and Biophotonics incorporates the internationally recognized program at the Photonics Research Laboratory while bringing together active multidisciplinary faculty from Medicine, Dental Biology, Engineering, Physics and Chemistry. The Institute strives to produce leading edge technologies while providing education and training of critical needs in this growth industry.
The Center for Advanced Technology in Biomedical and Bioengineering at the University at Buffalo (CAT) focuses on biomedical and bioengineering translational research for development of useful products with commercial potential. Programs include matching grants for mid-to-late stage development of drugs, biologics, diagnostics, devices, services, or other related products with commercial potential.
The Center in Biomolecular Diagnostics and Therapeutics at SUNY Stony Brook conducts research and technology development in the areas of functional genomics instrumentation, gene discovery, drug design and delivery, and smart micro- and nano-based biomaterials and biosensors. The STAR Center built upon Stony Brook's existing expertise in these areas and that of its partners, Brookhaven National Laboratory and Cold Spring Harbor Laboratory, advances the biotechnology corridor of Long Island and across New York by developing new biomedical technologies, opening up new markets and advancing disease diagnosis and treatment.
SUNY Stony Brook’s Center of Advanced Technology in Medical Biotechnology (CAT) is involved in the discovery, development, translation and commercialization of promising biotechnology resulting from academic research centers around New York State. This ranges from diagnostics to gene discovery, medical devices to therapeutics involved in the discovery, development, translation and commercialization of promising biotechnology resulting from academic research centers around the state, ranging from diagnostics to gene discovery, medical devices to therapeutics.
The New York Structural Biology Center at City University of New York represents a unique facility that provides New York’s internationally leading researchers with state-of-the-art equipment for research collaboration. This STAR Center’s Chief partners are Albert Einstein College of Medicine, Columbia University, Memorial Sloan-Kettering Cancer Center, Mount Sinai School of Medicine, New York University, the Rockefeller University, Wadsworth Center Laboratory and Weill Medical College of Cornell University.
The Center for Integrated Multilevel Analysis of Neuronal Plasticity at the Mount Sinai School of Medicine supports cutting-edge research to better understand how biological systems are organized so that more effective therapies can be developed to prevent and combat disease.  Researchers from the host institution Mount Sinai School of Medicine and three participating institutions, Columbia University, Cold Spring Harbor Laboratory and SUNY Stony Brook, have joined together to form a large national and international multidisciplinary research consortium focused on a large-scale collaborative project on complex biological systems.
Center for Advanced Information Management at Columbia University (CAT) specializes in developing information technologies at the interface between biomedical and communications sciences. The CAT utilizes scientific, clinical and engineering talent at Columbia University from several groups in the medical center and engineering school to provide companies with information-based expertise from its technology leaders.
Also at Columbia University, the Integrated Imaging Center develops new technologies to improve the diagnosis and treatment of neurodegenerative and psychiatric disorders. The STAR Center helps make Columbia University’s renowned as a world leader in neuroscience research.
The Genomic Technologies & Information Sciences Center at Cornell University builds on Cornell’s outstanding expertise in life sciences research. With the help of its world-class partners, Cold Spring Harbor Laboratory, IBM and Corning, the STAR Center develops cutting-edge technologies for identifying genes and gene functions that will lead to applications of genomic theories and technologies in agriculture, biosciences and veterinary medicine.
The Nanobiotechnology Center at Cornell University features a close collaboration between life scientists, physical scientists and engineers. It has a fully integrated education and outreach effort in which all faculty staff participates. The Center brings together experts in their fields from Cornell University, the Wadsworth Center Princeton University, Oregon Health & Science University, Clark Atlanta University and Howard University. It also involves the active collaboration of K-12 educators and representatives from industry and government.
Also at Cornell University, The Center for Life Science Enterprise (CAT) supports research and technology development programs in partnership with New York companies representing diverse disciplines including chemistry, engineering, food science, genetics, microbiology, molecular biology, plant science and veterinary medicine.
The Center for Excellence in Cancer Genomics at the University at Albany is committed to research that will discover the genetic origins of cancer and lead to finding a cure for the disease. The central mission of the Center is to conduct research and provide training related to understanding the genetic and environmental causes of cancer.
The Center for Pharmacogenomics at Albany Medical College identifies candidate genes for disease susceptibility, as well as adverse reactions to chemicals and drugs. Findings are used to develop new technologies, including those that uncover susceptibility to drug therapies. Chief partners are Wadsworth Center Laboratory and Health Research, Inc.
The Center for Bioengineering and Medicine at Rensselaer Polytechnic Institute supports essential infrastructure, including laboratory equipment and facilities within the Center for Biotechnology and Interdisciplinary Studies and augments RPI's fundamental research in accelerated drug discovery and synthesis; biosensors and monitoring; and tissue repair and replacement.
Center for Biotechnology Education and Training at Rochester Institute of Technology strives to prepare biotechnology and other bioscience workers for the rapid changes in science, technology and the knowledge base needed for competitiveness in the global marketplace by continuously upgrading the skills of the region’s deployed workforce though a series of customized workshops, seminars and training programs.
Central New York Biotechnology Research Center at SUNY Upstate provides access to the high-caliber technology necessary to commercialize biotechnical products and services. A key component of the center is its world-class core facilities for DNA, proteomic, bioinformatics and tissue-engineering technologies.
The Center for Immunology Research at Trudeau University is a world-class medical research facility dedicated to working with scientists from around the world to better understand the immune system.
The Broad Hollow Bioscience Park is devoted to supporting the development of biotech start-up companies by utilizing shared facility resources, the resources of the Farmingdale State University campus, partnering with surrounding businesses and research institutions, and clustering the growing biotech companies into the Route 110 Bioscience Corridor.  The facility is home to the research headquarters of OSI Pharmaceuticals, Inc. the anchor tenant of the Park.


Return to Life Sciences - Main.